MARKET

ABPO

ABPO

ABPRO HLDGS INC
OTCPK
0.115
-0.005
-4.17%
Opening 09:39 03/12 EDT
OPEN
0.120
PREV CLOSE
0.120
HIGH
0.120
LOW
0.115
VOLUME
1.53K
TURNOVER
182
52 WEEK HIGH
29.97
52 WEEK LOW
0.087
MARKET CAP
312.37K
P/E (TTM)
-0.0047
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ABPO last week (0302-0306)?
Weekly Report · 3d ago
Weekly Report: what happened at ABPO last week (0223-0227)?
Weekly Report · 03/02 09:13
*News On Abpro Holdings Inc. (ABP) Now Under ABPO
Dow Jones · 02/23 22:08
Weekly Report: what happened at ABP last week (0216-0220)?
Weekly Report · 02/23 09:13
Abpro Holdings Faces Nasdaq Delisting, Plans Appeal
TipRanks · 02/20 21:59
Nasdaq Orders Abpro Holdings Delisting for Minimum Equity Noncompliance
Reuters · 02/20 21:16
Weekly Report: what happened at ABP last week (0209-0213)?
Weekly Report · 02/16 09:13
Is Abpro Holdings Inc Gaining or Losing Market Support?
Benzinga · 02/12 15:00
More
About ABPO
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Webull offers ABPRO Holdings Inc stock information, including OTCPK: ABPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABPO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABPO stock methods without spending real money on the virtual paper trading platform.